Does NIRAPARIB Cause Product dose omission issue? 1,852 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,852 reports of Product dose omission issue have been filed in association with NIRAPARIB (ZEJULA). This represents 8.6% of all adverse event reports for NIRAPARIB.
1,852
Reports of Product dose omission issue with NIRAPARIB
8.6%
of all NIRAPARIB reports
35
Deaths
443
Hospitalizations
How Dangerous Is Product dose omission issue From NIRAPARIB?
Of the 1,852 reports, 35 (1.9%) resulted in death, 443 (23.9%) required hospitalization, and 13 (0.7%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 1,852 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which NIRAPARIB Alternatives Have Lower Product dose omission issue Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP